PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Maternal prenatal depressive symptoms and fetal growth during the critical rapid growth stage

JAMA Network Open

2023-12-04
(Press-News.org)

About The Study: Maternal depressive symptoms were associated with slower fetal growth rate in the critical rapid growth stage before delivery in this study including 2,676 mother-offspring dyads. Early screening for depressive disorders in pregnant women appears to be essential for fetal growth and later health. 

Authors: Zhenmi Liu, Ph.D., and Jiaqiang Liao, Ph.D., of Sichuan University in Chengdu, China, are the corresponding authors. 

 To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2023.46018)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.46018?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120423

END



ELSE PRESS RELEASES FROM THIS DATE:

About 20% of patients listed as alive in their electronic health records were actually deceased according to California data

2023-12-04
About 20 % of patients whose medical records showed them as being alive with a serious illness were in fact deceased according to California data, leading to hundreds of unnecessary interactions such as appointment reminders, prescription refills and other kinds of wasteful outreach that strain resources and healthcare workers’ time. The data gap is due to California law that makes these full death data available only “for purposes of law enforcement or preventing fraud,” according to a UCLA-lead research team. Even a real-time death database maintained by the National Association for Public Health ...

Dietary environmental factors shape the immune defense against Cryptosporidium infection

2023-12-04
Francis Crick Institute press release Under strict embargo: 16:00hrs GMT Monday 4 December 2023 Peer reviewed Experimental study Animals   Researchers at the Francis Crick Institute have discovered that a common dietary supplement could protect against chronic Cryptosporidium infections which are particularly prevalent in children under two and in areas with poorer sanitation. Cryptosporidium is a parasite that infects and damages the small intestine. It is one of the leading causes of diarrhoea-related deaths ...

New study maps ketamine's effects on brain

2023-12-04
Ketamine – an anesthetic also known for its illicit use as a recreational drug – has undergone a thorough reputational rehabilitation in recent years as the medical establishment has begun to recognize its wide-ranging therapeutic effects. The drug is increasingly used for a range of medical purposes, including as a painkiller alternative to opioids, and as a therapy for treatment-resistant depression. In a new study published in the journal Cell Reports, Columbia biologists and biomedical engineers mapped ketamine’s effects on the brains of mice, and found that repeated use over extended periods of time leads to widespread structural changes in the brain’s ...

Studies help explain why some prostate cancers become resistant to hormone therapy

2023-12-04
Two new studies led by researchers from the UCLA Jonsson Comprehensive Cancer Center give insight into how cells use energy to influence the way prostate tumors survive and grow — advancements that can help explain why some prostate cancers become resistant to hormone therapy, the most commonly used treatment for men with advanced stages of the disease. Hormone therapy, also known as antiandrogen therapy, plays a crucial role in temporarily halting the growth of prostate cancer cells. Over time, however, the majority of patients eventually see their cancer return and progress, underscoring the pressing need for continued advancements to enhance clinical ...

Hard to drug: Protein droplets reveal new ways to inhibit transcription factors in an aggressive form of prostate cancer

Hard to drug: Protein droplets reveal new ways to inhibit transcription factors in an aggressive form of prostate cancer
2023-12-04
Many of the most potent human oncoproteins belong to a class of proteins called transcription factors, but designing small molecule drugs that target transcription factors is a major challenge. An international team of researchers from the Institute for Research in Biomedicine (IRB Barcelona), the Max Planck Institute for Molecular Genetics (MPIMG), BC Cancer (University of British Columbia) and other institutions has discovered a potential way to target the androgen receptor, the most prominent oncogenic transcription factor in prostate cancer, based on its propensity to form droplets also known as condensates. The results described ...

MD Anderson’s Katy Rezvani, M.D., receives 2023 Honorific Award from the American Society of Hematology

2023-12-04
Katy Rezvani, M.D., Ph.D., professor of Stem Cell Transplantation & Cellular Therapy at The University of Texas MD Anderson Cancer Center, has been honored with the E. Donnall Thomas Lecture and Prize from the American Society of Hematology (ASH) for her groundbreaking research to develop and advance innovative cell therapies for cancer using natural killer (NK) cells. “I am fortunate to be able to engage in research that I am passionate about, to mentor incredible young scientists, and to collaborate with a remarkable team of researchers and clinicians. But most importantly, I am blessed to have the opportunity to undertake research that has the potential to ...

Salty immune cells surrounding the brain linked to hypertension-induced dementia

Salty immune cells surrounding the brain linked to hypertension-induced dementia
2023-12-04
A study supported by the National Institutes of Health suggests that the response of immune system cells inside the protective covering surrounding the brain may contribute to the cognitive decline that can occur in a person with chronic high blood pressure. This finding, published in Nature Neuroscience, may shed light on new ways to counteract the effects of high blood pressure on cognition. The study was funded by the National Institute of Neurological Disorders and Stroke (NINDS), a part of NIH. “The role of immune signaling in cognitive decline is critically important to understand,” said Roderick Corriveau, Ph.D., program director, NINDS. “These findings offer insight ...

Dark galactic region nicknamed "The Brick" explained with Webb telescope findings

2023-12-04
In a recent study led by University of Florida astronomer Adam Ginsburg, groundbreaking findings shed light on a mysterious dark region at the center of the Milky Way. The turbulent gas cloud, playfully nicknamed “The Brick” due to its opacity, has sparked lively debates within the scientific community for years. To decipher its secrets, Ginsburg and his research team, including UF graduate students Desmond Jeff, Savannah Gramze, and Alyssa Bulatek, turned to the James Webb Space Telescope (JWST). The implications of their observations, published in ...

Awareness, accessibility, and affordability are crucial for the early detection of thalassemia

Awareness, accessibility, and affordability are crucial for the early detection of thalassemia
2023-12-04
- Interviewing Dr. Androulla Eleftheriou, Executive Director at TIF, and Dr. Zhiyu Peng, Deputy GM at BGI Genomics, Head of the World Hemoglobinopathy Foundation Thalassemia, a hereditary hemoglobinopathy, occurs in 4.4 out of every 10,000 live births and is prevalent in Mediterranean coastal areas, Africa, the Middle East, Southeast Asia, and southern China. Screening and antenatal diagnosis reduced the frequency of β-thalassemia in many Mediterranean countries. Focusing on other regions with high thalassemia prevalence, BGI Genomics has launched the Global 2023 State of Thalassemia Awareness Report, covering 1,847 ...

Complications from flu largely preventable with annual flu vaccine

2023-12-04
ARLINGTON, Va., BETHESDA, Md., CHICAGO and DALLAS, Dec. 4, 2023 — During National Influenza Vaccination Week (December 4-8, 2023), leading public health organizations are encouraging everyone to get a flu shot if they have not already done so. The flu is more than an inconvenience: it can lead to hospitalization, worsening of chronic medical conditions or even death. An annual flu vaccine is the best way to help prevent complications from the flu. [1] The American Heart Association®, the American Lung Association,® the American ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Maternal prenatal depressive symptoms and fetal growth during the critical rapid growth stage
JAMA Network Open